Conclusion paragraph
Despite the clinical burden of severe asthma is substantial, there is
evidence of a neutral effect of severe asthma in the clinical
progression and hospitalization due to COVID-19 in a cohort of Italian
severe asthma patients. Treatment with biologics for severe asthma also
seems to have no significant effect on the outcome of COVID-19.